M. K. Hahn

发表

The functional impact of SLC6 transporter genetic variation.

R. Blakely, M. K. Hahn, 2007, Annual review of pharmacology and toxicology.

A genetic screen in Caenorhabditis elegans for dopamine neuron insensitivity to 6‐hydroxydopamine identifies dopamine transporter mutants impacting transporter biosynthesis and trafficking

R. Blakely, T. Jessen, R. Nass, 2005, Journal of neurochemistry.

Functional coding variation in the presynaptic dopamine transporter associated with neuropsychiatric disorders drives enhanced motivation and context-dependent impulsivity in mice

Randy D. Blakely, R. Blakely, G. Stanwood, 2018, Behavioural Brain Research.

Title: Sex and Circuit Specific Dopamine Transporter Regulation Underlies Unique Behavioral Trajectories of Functional SLC6A3 Coding Variation Running Title (50 Characters): Sexual dimorphism in DAT Val559 mice Authors/Affiliations

R. Blakely, R. Vaughan, Keeley Spiess, 2021 .

Extracellular Norepinephrine Clearance by the Norepinephrine Transporter Is Required for Skeletal Homeostasis*

J. Nyman, S. Uppuganti, M. K. Hahn, 2013, The Journal of Biological Chemistry.

Regulation of autism-relevant behaviors by cerebellar–prefrontal cortical circuits

Margot J. Taylor, Brad E. Pfeiffer, Catherine J. Stoodley, 2020, Nature Neuroscience.

Hereditary dysautonomias: current knowledge and collaborations for the future

Linda J. Smith, K. Gwinn‐Hardy, D. O'Connor, 2003, Clinical Autonomic Research.

Norepinephrine transporter variant A457P knock-in mice display key features of human postural orthostatic tachycardia syndrome

Jana K. Shirey-Rice, A. Diedrich, J. Shirey-Rice, 2013, Disease Models & Mechanisms.

Norepinephrine Transporter Deficiency

M. K. Hahn, 2012 .

Norepinephrine Transporter Dysfunction

M. K. Hahn, 2004 .

Genetic Basis of Clinical Catecholamine Disorders

R. Blakely, Kwang-Soo Kim, I. Biaggioni, 2002, Annals of the New York Academy of Sciences.

Behaviorally penetrant, anomalous dopamine efflux exposes sex and circuit dependent regulation of dopamine transporters.

R. Blakely, R. Vaughan, M. K. Hahn, 2022, Molecular psychiatry.

Monoamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders

R. Blakely, M. K. Hahn, 2002, The Pharmacogenomics Journal.

A Mutation in the Human Norepinephrine Transporter Gene (SLC6A2) Associated with Orthostatic Intolerance Disrupts Surface Expression of Mutant and Wild-Type Transporters

R. Blakely, M. K. Hahn, D. Robertson, 2003, The Journal of Neuroscience.

Sympathetic neuron–associated macrophages contribute to obesity by importing and metabolizing norepinephrine

Ana I. Domingos, C. Glass, N. Spann, 2017, Nature Medicine.

Good riddance to dopamine: Roles for the dopamine transporter in synaptic function and dopamine-associated brain disorders

R. Blakely, M. K. Hahn, Raajaram Gowrishankar, 2014, Neurochemistry International.

Gene Organization and Polymorphisms of Monoamine Transporters Relationship to Psychiatric and Other Complex Diseases

R. Blakely, M. K. Hahn, 2013 .

Antidepressant-Sensitive Norepinephrine Transporters

M. K. Hahn, 2012 .

Gene Organization and Polymorphisms of Monoamine Transporters

R. Blakely, M. K. Hahn, 2002 .

Genetic variation in alpha2-adrenoreceptors and heart rate recovery after exercise.

R. Blakely, P. Kannankeril, A. Diedrich, 2015, Physiological genomics.

Genetic variation in the presynaptic norepinephrine transporter is associated with blood pressure responses to exercise in healthy humans

R. Blakely, C. Stein, M. K. Hahn, 2011, Pharmacogenetics and genomics.

Norepinephrine transporter heterozygous knockout mice exhibit altered transport and behavior

J. Shirey-Rice, M. K. Hahn, J. J. Krueger, 2013, Genes, brain, and behavior.

Novel and functional norepinephrine transporter protein variants identified in attention-deficit hyperactivity disorder

M. Stein, M. K. Hahn, R. Couch, 2009, Neuropharmacology.

Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: On the path to an animal model of attention-deficit hyperactivity disorder

R. Blakely, T. Jessen, G. Stanwood, 2014, Neurochemistry International.

Choline transporter gene variation is associated with attention-deficit hyperactivity disorder

Randy D. Blakely, Irwin D. Waldman, Brett A. English, 2009, Journal of Neurodevelopmental Disorders.

The rare DAT coding variant Val559 perturbs DA neuron function, changes behavior, and alters in vivo responses to psychostimulants

R. Blakely, John T. Williams, G. Stanwood, 2014, Proceedings of the National Academy of Sciences.

Serotonin transporter inhibition and 5-HT2C receptor activation drive loss of cocaine-induced locomotor activation in DAT Val559 mice

R. Blakely, F. Carroll, M. K. Hahn, 2018, Neuropsychopharmacology.

Region-Specific Regulation of Presynaptic Dopamine Homeostasis by D2 Autoreceptors Shapes the In Vivo Impact of the Neuropsychiatric Disease-Associated DAT Variant Val559

R. Blakely, R. Vaughan, M. K. Hahn, 2018, The Journal of Neuroscience.

There's no place like home? Return to the home cage triggers dopamine release in the mouse nucleus accumbens

R. Blakely, M. K. Hahn, H. Iwamoto, 2020, Neurochemistry International.

A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder

Martin H. Teicher, B. Cohen, M. S. Mazei-Robinson, 2006, Proceedings of the National Academy of Sciences.

Multivariate permutation analysis associates multiple polymorphisms with subphenotypes of major depression

B A English, R. Shelton, R. Blakely, 2008, Genes, brain, and behavior.

Single Nucleotide Polymorphisms in the Human Norepinephrine Transporter Gene Affect Expression, Trafficking, Antidepressant Interaction, and Protein Kinase C Regulation

R. Blakely, M. K. Hahn, M. Mazei-Robison, 2005, Molecular Pharmacology.

Analysis of tyrosine hydroxylase gene transcription using an intron specific probe

M. Zigmond, M. Austin, M. K. Hahn, 2000, Journal of Neuroscience Methods.

Single Nucleotide Polymorphisms in the Human Norepinephrine Transporter Gene Affect Expression, Trafficking, Antidepressant Interaction, and Protein Kinase C Regulation

R. Blakely, M. K. Hahn, Michelle S. Mazei-Robison, 2005, Molecular Pharmacology.